Fatigue in SLE: diagnostic and pathogenic impact of anti-N-methyl-D-aspartate receptor (NMDAR) autoantibodies.
Andreas SchwartingTamara MöckelFreya LütgendorfKonstantinos TriantafylliasSophia GrellaSimone BoedeckerArndt WeinmannMyriam MeineckClemens SommerIngrid SchermulyAndreas FellgiebelFelix LuessiJulia Weinmann-MenkePublished in: Annals of the rheumatic diseases (2019)
The presence of anti-NR2 antibodies in patients with SLE with fatigue is a helpful diagnostic tool and may offer a major approach in the therapeutic management of this important disabling symptom in patients with SLE.